T. Berghmans

782 total citations
21 papers, 508 citations indexed

About

T. Berghmans is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, T. Berghmans has authored 21 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in T. Berghmans's work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Diagnosis and Treatment (11 papers) and Lung Cancer Research Studies (9 papers). T. Berghmans is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Diagnosis and Treatment (11 papers) and Lung Cancer Research Studies (9 papers). T. Berghmans collaborates with scholars based in Belgium, France and Spain. T. Berghmans's co-authors include J.P. Sculier, Marianne Paesmans, Céline Mascaux, J.J. Lafitte, A.-P. Meert, M. Paesmans, Annick Haller, Bénédicte Martin, J.J. Lafitte and Vincent Ninane and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and British Journal of Cancer.

In The Last Decade

T. Berghmans

16 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Berghmans Belgium 11 276 251 103 94 48 21 508
Jin Woo Kim South Korea 16 368 1.3× 126 0.5× 100 1.0× 90 1.0× 40 0.8× 38 608
Luís Corral-Gudino Spain 13 219 0.8× 264 1.1× 92 0.9× 83 0.9× 35 0.7× 57 665
Juan Bertó Spain 13 628 2.3× 157 0.6× 65 0.6× 104 1.1× 40 0.8× 25 812
Pablo Sánchez-Salcedo Spain 14 649 2.4× 139 0.6× 64 0.6× 82 0.9× 35 0.7× 20 792
Malene Cramer Engebjerg Denmark 10 144 0.5× 105 0.4× 50 0.5× 95 1.0× 149 3.1× 14 601
Vladimír Koblížek Czechia 16 637 2.3× 114 0.5× 57 0.6× 73 0.8× 47 1.0× 62 862
Jongha Park South Korea 15 365 1.3× 384 1.5× 58 0.6× 162 1.7× 238 5.0× 71 775
Debra J. Szeluga United States 11 79 0.3× 217 0.9× 79 0.8× 82 0.9× 118 2.5× 22 430
J. Montesinos Spain 13 154 0.6× 143 0.6× 21 0.2× 68 0.7× 75 1.6× 35 493
Chunhuan Lao New Zealand 11 83 0.3× 188 0.7× 66 0.6× 41 0.4× 44 0.9× 57 399

Countries citing papers authored by T. Berghmans

Since Specialization
Citations

This map shows the geographic impact of T. Berghmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Berghmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Berghmans more than expected).

Fields of papers citing papers by T. Berghmans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Berghmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Berghmans. The network helps show where T. Berghmans may publish in the future.

Co-authorship network of co-authors of T. Berghmans

This figure shows the co-authorship network connecting the top 25 collaborators of T. Berghmans. A scholar is included among the top collaborators of T. Berghmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Berghmans. T. Berghmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wolf, Julien De, C. Le Péchoux, & T. Berghmans. (2024). Cancers bronchiques non à petites cellules de stade III : quel abord local optimal ?. Revue des Maladies Respiratoires Actualités. 16(2). 2S82–2S93.
2.
Morfouace, Marie, Silvia Novello, Christophe Dooms, et al.. (2022). Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform. Scientific Reports. 12(1). 8342–8342. 1 indexed citations
3.
Berghmans, T., et al.. (2020). La classification TNM en pratique. Revue des Maladies Respiratoires Actualités. 12(2). 2S53–2S60.
4.
Ameye, Lieveke, et al.. (2016). Score inflammatoire de Glasgow et cancer bronchique : une aide pour hospitaliser aux urgences. Revue des Maladies Respiratoires. 33(9). 759–765. 1 indexed citations
5.
Jungels, Christiane, T. Berghmans, A.-P. Meert, et al.. (2011). Traitement de rattrapage par pémétrexed pour les CBNPC : étude rétrospective d’implémentation. Revue des Maladies Respiratoires. 29(1). 21–27. 4 indexed citations
6.
Jp, Sculier, T. Berghmans, Frédéric Lemaître, & Frédéric Vallot. (2008). La ventilation artificielle chez les patients atteints de cancer. Revue des Maladies Respiratoires. 18(2). 137–154.
7.
Berghmans, T.. (2008). Cancers bronchiques non à petites cellules résécables : chimiothérapie (néo) adjuvante. Revue des Maladies Respiratoires. 25(8). 3S72–3S78.
8.
Sculier, Jean‐Paul, J.J. Lafitte, Marianne Paesmans, et al.. (2007). Chemotherapy improves low performance status lung cancer patients. European Respiratory Journal. 30(6). 1186–1192. 20 indexed citations
9.
Berghmans, T., M. Paesmans, Céline Mascaux, et al.. (2006). Thyroid transcription factor 1—a new prognostic factor in lung cancer: a meta-analysis. Annals of Oncology. 17(11). 1673–1676. 111 indexed citations
10.
Berghmans, T., Céline Mascaux, Benoı̂t Martin, Vincent Ninane, & Jean‐Paul Sculier. (2006). Prognostic role of thyroid transcription factor-1 in stage III non-small cell lung cancer. Lung Cancer. 52(2). 219–224. 14 indexed citations
11.
Mascaux, Céline, et al.. (2006). [Docetaxel as salvage treatment for non-small cell lung cancer: implementation study].. PubMed. 26(3). 153–8. 3 indexed citations
12.
Berghmans, T., A-P Meert, Vincent Ninane, & Sculier Jp. (2005). Mitomycin, ifosfamide, cisplatin for non-small cell lung cancer: an implementation study. Monaldi Archives for Chest Disease. 63(4). 184–92. 1 indexed citations
13.
Berghmans, T., et al.. (2005). Prognostic role of epidermal growth factor receptor in stage III nonsmall cell lung cancer. European Respiratory Journal. 25(2). 329–335. 17 indexed citations
14.
15.
Berghmans, T., A.-P. Meert, Céline Mascaux, et al.. (2003). Citation indexes do not reflect methodological quality in lung cancer randomised trials. Annals of Oncology. 14(5). 715–721. 32 indexed citations
16.
Berghmans, T., M Paesmans, J.J. Lafitte, et al.. (2002). Therapeutic use of granulocyte and granulocyte-macrophage colony-stimulating factors in febrile neutropenic cancer patients. Supportive Care in Cancer. 10(3). 181–188. 58 indexed citations
17.
18.
Sculier, J.P., J.J. Lafitte, T. Berghmans, et al.. (2000). A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer. Lung Cancer. 29(1). 67–73. 41 indexed citations
19.
20.
Berghmans, T.. (1996). Hyponatremia related to medical anticancer treatment. Supportive Care in Cancer. 4(5). 341–350. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jin Woo Kim Breakdown of academic impact, for papers by Luís Corral-Gudino Breakdown of academic impact, for papers by Juan Bertó Breakdown of academic impact, for papers by Pablo Sánchez-Salcedo Breakdown of academic impact, for papers by Malene Cramer Engebjerg Breakdown of academic impact, for papers by Vladimír Koblížek Breakdown of academic impact, for papers by Jongha Park Breakdown of academic impact, for papers by Debra J. Szeluga Breakdown of academic impact, for papers by J. Montesinos Breakdown of academic impact, for papers by Chunhuan Lao
Rankless by CCL
2026